Clincosm LogoSign in Get a demo

Glioblastoma Multiforme

Showing NaN - NaN of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme Trial in United States (Keto Diet, Usual Diet)

Not yet recruiting
  • Glioblastoma Multiforme
  • Keto Diet
  • Usual Diet
  • Los Angeles, California
  • +4 more
Jan 31, 2023

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +3 more
Jan 16, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

Recruiting
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +12 more
Jan 9, 2023

Multiple Myeloma, DLBCL, Glioblastoma Multiforme Trial in Worldwide (CC-223)

Completed
Has Results
  • Multiple Myeloma
  • +6 more
  • Los Angeles, California
  • +15 more
Dec 9, 2022

Glioblastoma Multiforme Trial in United States (ERAS-801)

Recruiting
  • Glioblastoma Multiforme
  • Los Angeles, California
  • +6 more
Nov 14, 2022

Glioblastoma Multiforme Trial in Los Angeles, Cleveland (Perillyl alcohol)

Recruiting
  • Glioblastoma Multiforme
  • Perillyl alcohol
  • Los Angeles, California
  • +1 more
Sep 23, 2022

Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)

Active, not recruiting
  • Glioblastoma Multiforme
  • VBI-1901
  • +2 more
  • Los Angeles, California
  • +3 more
Jun 27, 2022

Glioblastoma, Glioblastoma Multiforme Trial in United States (drug, other, radiation)

Recruiting
  • Glioblastoma
  • Glioblastoma Multiforme
  • Los Angeles, California
  • +3 more
May 31, 2022

Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

Active, not recruiting
  • Glioblastoma Multiforme
  • +6 more
  • Dendritic cell immunotherapy
  • Birmingham, Alabama
  • +85 more
May 12, 2022

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Glioblastoma Multiforme Trial in Los Angeles (drug, radiation, procedure)

Recruiting
  • Glioblastoma Multiforme
  • Los Angeles, California
    Cedars-Sinai Medical Center
Feb 24, 2022

Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

Completed
  • Glioblastoma
  • +4 more
  • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
  • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 18, 2021

Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer Trial in Worldwide (CC-115)

Completed
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +16 more
Oct 4, 2021

Glioblastoma Multiforme, Anaplastic Oligoastrocytoma Trial in United States (Ad-RTS-hIL-12, veledimex)

Completed
  • Glioblastoma Multiforme
  • Anaplastic Oligoastrocytoma
  • Los Angeles, California
  • +5 more
Sep 21, 2021

Glioblastoma Multiforme Trial in Worldwide (drug, other, radiation)

Terminated
Has Results
  • Glioblastoma Multiforme
  • Steroid eye drops
  • +6 more
  • Los Angeles, California
  • +21 more
Mar 19, 2021

Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Bevacizumab)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Castro Valley, California
  • +16 more
May 26, 2020

Glioblastoma Multiforme, Astrocytoma, Gliomas, Malignant Trial in United States (Toca 511 vector, Toca FC • Flucytosine • 5-FC •

Terminated
  • Glioblastoma Multiforme
  • +2 more
  • Toca 511 vector
  • Toca FC • Flucytosine • 5-FC • 5-Fluorocytosine
  • Los Angeles, California
  • +10 more
Mar 26, 2020

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Worldwide (Toca 511, Toca FC, Lomustine)

Terminated
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Toca 511
  • +4 more
  • Phoenix, Arizona
  • +66 more
Feb 6, 2020

Glioblastoma Multiforme, Glioblastoma, Glioma Trial in United States (VAL-083, Dianhydrogalactitol, Physician's Choice of

Terminated
  • Glioblastoma Multiforme
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • +3 more
  • Los Angeles, California
  • +4 more
Nov 12, 2019

Glioblastoma Multiforme Trial in United States (Cilengitide 500 mg, Cilengitide 2000 mg)

Completed
Has Results
  • Glioblastoma Multiforme
  • Cilengitide 500 mg
  • Cilengitide 2000 mg
  • Birmingham, Alabama
  • +16 more
Jan 18, 2019

Glioblastoma Multiforme Trial in Austria, Canada, United States (ICT-107, Placebo)

Suspended
  • Glioblastoma Multiforme
  • ICT-107
  • Placebo
  • Birmingham, Alabama
  • +64 more
Aug 9, 2018

Glioblastoma Multiforme Trial in United States (ICT-121 DC vaccine)

Completed
  • Glioblastoma Multiforme
  • ICT-121 DC vaccine
  • Birmingham, Alabama
  • +5 more
Aug 9, 2018

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511, Toca FC)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Toca 511
  • Toca FC
  • Irvine, California
  • +5 more
May 16, 2018

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511 vector, Toca FC)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Toca 511 vector
  • Toca FC
  • Los Angeles, California
  • +7 more
May 16, 2018

Adult Brain Glioblastoma, Glioblastoma Multiforme Trial in United States (SL-701; poly-ICLC (polyinosinic-polycytidylic acid

Completed
  • Adult Brain Glioblastoma
  • Glioblastoma Multiforme
  • SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose)
  • Bevacizumab
  • Birmingham, Alabama
  • +15 more
Jan 24, 2018